FDA Inspection 814448 — KP Pharmaceutical Technology

KP Pharmaceutical Technology — FEI 3001802820

The FDA completed an inspection of KP Pharmaceutical Technology on December 17, 2012 in Bloomington, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 17, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bloomington, IN (United States)